
Is KVUE (Kenvue Inc.) Halal or Haram?
Kenvue Inc. successfully passes all AAOIFI shariah screening criteria, driven by its permissible core business in consumer healthcare. The company maintains a healthy balance sheet with a debt-to-market cap ratio of 25.3%, comfortably below the 33% threshold, and reports 0.00% interest income against revenue.
Price Chart (5D)
KVUE — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-05-01 | 17.69 | 17.71 | 17.32 | 17.43 | 9.9M | -1.47% |
| 2026-04-30 | 17.23 | 17.59 | 17.22 | 17.53 | 17.3M | +1.74% |
| 2026-04-29 | 17.46 | 17.59 | 17.05 | 17.23 | 13.3M | -1.32% |
| 2026-04-28 | 17.75 | 17.83 | 17.41 | 17.54 | 17.2M | -1.18% |
| 2026-04-27 | 17.43 | 17.66 | 17.40 | 17.53 | 30.0M | +0.57% |
| 2026-04-24 | 17.58 | 17.68 | 17.42 | 17.49 | 6.6M | -0.51% |
| 2026-04-23 | 17.34 | 17.53 | 17.34 | 17.49 | 13.8M | +0.87% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for KVUE
Business Activity
Permissible
Kenvue's business of manufacturing everyday consumer health products, including Tylenol, Neutrogena, and Listerine, is fundamentally permissible as it provides essential personal care and medical goods.
Debt / Market Cap
25.31%
Interest Income
0.00%
Cash & Securities
3.15%
About Kenvue Inc. (KVUE)
Kenvue Inc. is a leading global consumer health company that operates across self-care, skin health, and essential health segments. The company manufactures and distributes widely recognized household staples, including Tylenol, Zyrtec, Neutrogena, Aveeno, and Listerine.
For Muslim investors, Kenvue represents a strong, shariah-compliant addition to a defensive portfolio. The stock passes all AAOIFI screening criteria with an overall Halal rating, meaning its core business activities and financial structures align perfectly with Islamic finance principles.
From an Islamic finance perspective, Kenvue's balance sheet is reassuringly clean and avoids excessive leverage. The company's debt-to-market capitalization stands at an acceptable 25.3%, and its cash and interest-bearing securities make up just 3.2% of its market cap, minimizing exposure to riba-based instruments.
Since the company's product line consists almost entirely of permissible healthcare and hygiene items, there is no significant scholarly debate regarding its business model. However, halal investors should periodically monitor its debt-to-market cap ratio to ensure continued compliance during periods of market volatility.
KVUE Key Financial Statistics
Revenue
$15.12B
Net Income
$1.47B
EPS (Diluted)
$0.76
Stock Price
17.54
Beta
0.57
52-Week Range
14.02-25.17
Total Debt
$8.52B
Total Equity
$10.77B
Current Ratio
0.96
KVUE Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
-2.1%
Prior year: $15.46B
Net Debt
$7.46B
Cash: $1.06B — Debt: $8.52B
R&D Spending
$382.0M
% of Revenue
2.5%
Frequently Asked Questions About KVUE
Is KVUE (Kenvue Inc.) stock halal to invest in?▾
What does Kenvue Inc. do?▾
What screening criteria were used for KVUE?▾
Does KVUE require income purification?▾
When was KVUE last screened?▾
Disclaimer
This shariah compliance assessment for KVUE (Kenvue Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.